VivoSim Labs, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
VivoSim Labs, Inc. (VIVS) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$18.00 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2025-06-05
- VivoSim Labs, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$18.00K.
- VivoSim Labs, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was -$14.00K, a 1500.00% decline from fiscal 2023.
- VivoSim Labs, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $1.00K, a 95.00% decline from fiscal 2022.
- VivoSim Labs, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $20.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-03-31 | -$18.00K 10-K · filed 2025-06-05 | |
| 2024-03-31 | -$14.00K 10-K · filed 2025-06-05 | -$16.00K 10-K · filed 2024-05-31 |
| 2023-03-31 | $1.00K 10-K · filed 2024-05-31 | |
| 2022-03-31 | $20.00K 10-K · filed 2023-07-14 | |
| 2021-03-31 | -$215.00K 10-K · filed 2022-06-10 | |
| 2020-03-31 | $70.00K 10-K · filed 2021-06-15 | |
| 2019-03-31 | $2.79M 10-K · filed 2020-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |